Related Experiment Video
Updated: Jan 9, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Federated learning in inflammatory bowel disease: The future of privacy-preserving Artificial Intelligence
Pierluigi Puca1, Loris Riccardo Lopetuso2, Lucrezia Laterza3
1IBD Unit, CEMAD, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
Abstract:
Federated learning is an emerging paradigm in artificial intelligence that enables the training of robust models across decentralized datasets without requiring the physical transfer of sensitive data. This privacy-preserving approach has gained increasing traction in medical research, where data fragmentation and legal barriers often hinder the development of multicentric trials and AI applications. In this review, we first provide an explanation of federated learning's process and functioning. We then provide a structured overview of its implementation in clinical research, highlighting key multicentric studies in several fields of medicine. These studies consistently demonstrate that FL achieves comparable, and in some cases superior, diagnostic and prognostic performance in comparison to centralized learning approaches, with area under the curve values often exceeding 0.80. We then consider the potential of federated learning in the context of inflammatory bowel diseases, where data heterogeneity, geographic dispersion, and patient privacy concerns currently limit the development of large-scale predictive models. In doing so, we will provide specific focus on its application in multicentric trials and basic research. Finally, aspects like semantic interoperability in federated learning and privacy issues will also be discussed. We believe that federated learning could transform the way inflammatory bowel diseases datasets are utilized across institutions, facilitating collaborative algorithm development in areas such as treatment response prediction, endoscopic image analysis, and disease phenotyping-without compromising patient confidentiality.
More Related Videos
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...